How long should treatment with bevacizumab for degenerative maculopathy be monitored before determining it is ineffective, and what clinical symptoms should be assessed?
Fuente:
Zenodo
Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Published: |
Zenodo
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|